Mutations in rhodopsin are one of the most common causes of retinitis pigmentosa (RP). Misfolding of rhodopsin can result in disruptions in cellular protein homeostasis, or proteostasis. There is currently no available treatment for RP. In this review, we discuss the different approaches currently being investigated for treatment of rhodopsin RP, focusing on the potential of manipulation of the proteostasis network as a therapeutic approach to combat retinal degeneration.
CITATION STYLE
Parfitt, D. A., & Cheetham, M. E. (2016). Targeting the proteostasis network in rhodopsin retinitis pigmentosa. In Advances in Experimental Medicine and Biology (Vol. 854, pp. 479–484). Springer New York LLC. https://doi.org/10.1007/978-3-319-17121-0_64
Mendeley helps you to discover research relevant for your work.